Does bronchiectasis affect chronic obstructive pulmonary disease comorbidities?

被引:3
作者
Nowinski, Adam [1 ]
Korzybski, Damian [1 ]
Bednarek, Michal [1 ]
Goljan-Geremek, Anna [1 ]
Puscinska, Elzbieta [1 ]
Sliwinski, Pawel [1 ]
机构
[1] Natl Res Inst TB & Lung Dis, Dept Resp Med 2, Warsaw, Poland
关键词
bronchiectasis; COPD; comorbidities; CHRONIC HEART-FAILURE; CO-MORBIDITY; MORTALITY;
D O I
10.5603/ARM.2019.0059
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Chronic obstructive pulmonary disease (COPD) and bronchiectasis, chronic inflammation disorders of the bronchial tree through the mechanism or 'spili-over` of inflammatory mediators, may lead to systemic manifestations of illness of the respiratory system and comorbidities. The aim of the study was to evaluate the frequency of coexisting COPD and bronchiectasis and influence of bronchiectasis on COPD comorbid diseases. Material and methods: A post-hoc cross-sectional analysis of cohort study of 288 consecutive patients hospitalized due to acute exacerbation of COPD was performed. Results: 177 males (61.5%) and 111 females (38.5%) with mean age = 71.0 8 +/- 8.9 years, FEV1% pred. = 34.6 +/- 16.8 with COPD diagnosis were studied. In this group, 29 (10.1%) patients presented with bronchiectasis confirmed by HRCT scan. COPD patients with and without bronchiectasis had similar Charlson index results (2.5 vs 2.1, p = 0.05). COPD patients with bronchiectasis required longer hospitalization during exacerbation. COPD patients with bronchiectasis significantly more often than patients without this comorbidity revealed the features of colonization with P aeruginosa (OR = 4.17, p = 0.02). Conclusions: Bronchiectasis is a relatively common comorbidity in COPD patients. COPD patients with bronchiectasis are more frequently colonized with P. aruginosa comparing to non-bronchiectasis COPD patients. We did not confirm the influence of bronchiectasis on COPD comorbidities.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 29 条
[1]   Characterisation of COPD heterogeneity in the ECLIPSE cohort [J].
Agusti, Alvar ;
Calverley, Peter M. A. ;
Celli, Bartolome ;
Coxson, Harvey O. ;
Edwards, Lisa D. ;
Lomas, David A. ;
MacNee, William ;
Miller, Bruce E. ;
Rennard, Steve ;
Silverman, Edwin K. ;
Tal-Singer, Ruth ;
Wouters, Emiel ;
Yates, Julie C. ;
Vestbo, Jorgen .
RESPIRATORY RESEARCH, 2010, 11
[2]   The Role of CT Scanning in Multidimensional Phenotyping of COPD [J].
Bafadhel, Mona ;
Umar, Imran ;
Gupta, Sumit ;
Raj, J. Vimal ;
Vara, Dhiraj D. ;
Entwisle, James J. ;
Pavord, Ian D. ;
Brightling, Christopher E. ;
Siddiqui, Salman .
CHEST, 2011, 140 (03) :634-642
[3]   Systemic manifestations and comorbidities of COPD [J].
Barnes, P. J. ;
Celli, B. R. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) :1165-1185
[4]   Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [J].
Calverley, P ;
Pauwels, R ;
Vestbo, J ;
Jones, P ;
Pride, N ;
Gulsvik, A ;
Anderson, J ;
Maden, C .
LANCET, 2003, 361 (9356) :449-456
[5]   Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention [J].
Campo, Gianluca ;
Guastaroba, Paolo ;
Marzocchi, Antonio ;
Santarelli, Andrea ;
Varani, Elisabetta ;
Vignali, Luigi ;
Sangiorgio, Pietro ;
Tondi, Stefano ;
Serenelli, Carlotta ;
De Palma, Rossana ;
Saia, Francesco .
CHEST, 2013, 144 (03) :750-757
[6]   The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study [J].
Chalmers, James D. ;
McDonnell, Melissa J. ;
Rutherford, Robert ;
Davidson, John ;
Finch, Simon ;
Crichton, Megan ;
Dupont, Lieven ;
Hill, Adam T. ;
Fardon, Thomas C. ;
De Soyza, Anthony ;
Aliberti, Stefano ;
Goeminne, Pieter .
RESPIRATORY MEDICINE, 2016, 112 :51-58
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[9]  
CURRIE DC, 1990, Q J MED, V76, P799
[10]   Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa [J].
Drobnic, ME ;
Suñé, P ;
Montoro, JB ;
Ferrer, A ;
Orriols, R .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) :39-44